ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer (LucaVax)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01579188
Recruitment Status : Unknown
Verified April 2012 by Kael-GemVax Co., Ltd..
Recruitment status was:  Not yet recruiting
First Posted : April 17, 2012
Last Update Posted : April 19, 2012
Sponsor:
Collaborator:
Quintiles, Inc.
Information provided by (Responsible Party):
Kael-GemVax Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2016
  Estimated Study Completion Date : May 2016